HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Insulin enhances the effect of nitric oxide at inhibiting neointimal hyperplasia in a rat model of type 1 diabetes.

Abstract
Diabetes confers greater restenosis from neointimal hyperplasia following vascular interventions. While localized administration of nitric oxide (NO) is known to inhibit neointimal hyperplasia, the effect of NO in type 1 diabetes is unknown. Thus the aim of this study was to determine the efficacy of NO following arterial injury, with and without exogenous insulin administration. Vascular smooth muscle cells (VSMC) from lean Zucker (LZ) rats were exposed to the NO donor, DETA/NO, following treatment with different glucose and/or insulin concentrations. DETA/NO inhibited VSMC proliferation in a concentration-dependent manner to a greater extent in VSMC exposed to normal-glucose vs. high-glucose environments, and even more effectively in normal-glucose/high-insulin and high-glucose/high-insulin environments. G(0)/G(1) cell cycle arrest and cell death were not responsible for the enhanced efficacy of NO in these environments. Next, type 1 diabetes was induced in LZ rats with streptozotocin. The rat carotid artery injury model was performed. Type 1 diabetic rats experienced no significant reduction in neointimal hyperplasia following arterial injury and treatment with the NO donor PROLI/NO. However, daily administration of insulin to type 1 diabetic rats restored the efficacy of NO at inhibiting neointimal hyperplasia (60% reduction, P < 0.05). In conclusion, these data demonstrate that NO is ineffective at inhibiting neointimal hyperplasia in an uncontrolled rat model of type 1 diabetes; however, insulin administration restores the efficacy of NO at inhibiting neointimal hyperplasia. Thus insulin may play a role in regulating the downstream beneficial effects of NO in the vasculature.
AuthorsVinit N Varu, Sadie S Ahanchi, Melissa E Hogg, Hussein A Bhikhapurwala, Amy Chen, Daniel A Popowich, Ashley K Vavra, Janet Martinez, Qun Jiang, Joseph E Saavedra, Joseph A Hrabie, Larry K Keefer, Melina R Kibbe
JournalAmerican journal of physiology. Heart and circulatory physiology (Am J Physiol Heart Circ Physiol) Vol. 299 Issue 3 Pg. H772-9 (Sep 2010) ISSN: 1522-1539 [Electronic] United States
PMID20562340 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, N.I.H., Intramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)
Chemical References
  • Insulin
  • Nitric Oxide
Topics
  • Analysis of Variance
  • Animals
  • Aorta (drug effects, metabolism, pathology)
  • Carotid Arteries (drug effects, metabolism, pathology)
  • Cell Death (drug effects)
  • Cell Proliferation (drug effects)
  • Cells, Cultured
  • Diabetes Mellitus, Experimental (metabolism, pathology)
  • Diabetes Mellitus, Type 1 (metabolism, pathology)
  • Drug Interactions
  • Flow Cytometry
  • Hyperplasia (metabolism, pathology)
  • Insulin (metabolism, pharmacology)
  • Muscle, Smooth, Vascular (drug effects, metabolism, pathology)
  • Myocytes, Smooth Muscle (drug effects, metabolism, pathology)
  • Nitric Oxide (metabolism, pharmacology)
  • Rats
  • Tunica Intima (drug effects, metabolism, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: